Isoniazid Tablet
Product Images NDC 51079-083

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Isoniazid (NDC 51079-083). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Isoniazid 300 mg Tablets Unit Carton Label (Image 01)

Isoniazid is a prescription drug available in the form of tablets, USP, with each tablet containing 300 mg oz, USP. The tablets are to be stored between 20°C and 25°C and protected from light and moisture. The manufacturer of the drug is Teva Pharmaceuticals USA, Inc. and Patheon Inc. from Canada with the prescription form provided.*

FDA Label Image

Serialized Unit Carton (Image 02)

This is a warning label found on a drug package. It informs that the package is not child-resistant and is only suitable for institutional use. There is a cautionary note to keep all drugs out of the reach of children. The container provides light-resistance, and further information regarding the lot number and expiration date is available on the window. The label also mentions Mylan® drugs and an address in Rockford, Illinois.*

FDA Label Image

Image 03

FDA Label Image

Isoniazid Structure (Image 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.